Epimutational Profile of Hematologic Malignancies as Attractive Target for New Epigenetic Therapies

Oncotarget - United States
doi 10.18632/oncotarget.10033
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2017English

The MUC1-C Oncoprotein as a Target in Hematologic Malignancies

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

CD19-Targeted T Cells for Hematologic Malignancies

Cancer Journal
Cancer ResearchOncology
2015English

Hematologic Malignancies in Thalassemia: Adding New Cases to the Repertoire

American Journal of Hematology
Hematology
2017English

Vaccine Therapy in Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Pharmacotherapy of Hematologic Malignancies With Tipifarnib

Clinical Medicine. Therapeutics
2009English

Immune Checkpoint Blockade for Hematologic Malignancies: A Review

Stem Cell Investigation
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy